Your browser doesn't support javascript.
loading
Silencing circFTO inhibits malignant phenotype through modulating DUSP4 expression in clear cell renal cell carcinoma.
Yang, Chen; Zang, Yiwen; Wu, Siqi; Zhou, Quan; Ou, Yuxi; Ding, Qiang; Wang, Hao; Xiong, Zuquan.
Afiliação
  • Yang C; Huashan Hospital, Fudan University, Shanghai, China. YangC_Huashan@163.com.
  • Zang Y; Shanghai Medical College, Fudan University, Shanghai, China. YangC_Huashan@163.com.
  • Wu S; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. YangC_Huashan@163.com.
  • Zhou Q; Huashan Hospital, Fudan University, Shanghai, China.
  • Ou Y; Shanghai Medical College, Fudan University, Shanghai, China.
  • Ding Q; Huashan Hospital, Fudan University, Shanghai, China.
  • Wang H; Shanghai Medical College, Fudan University, Shanghai, China.
  • Xiong Z; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Cell Death Discov ; 8(1): 392, 2022 Sep 20.
Article em En | MEDLINE | ID: mdl-36127345
ABSTRACT
Clear cell renal cell carcinoma (ccRCC) is the most diagnosed malignancy in kidney. Studies on the role of circular RNAs in kidney cancer are increasing. In this study, we employed high throughput sequencing and tissue micro array to detect and verify one of the key circular RNAs, circFTO, in ccRCC. The effect of circFTO on the proliferation and invasiveness of ccRCC cells and the corresponding mechanism were studied both in vitro and in vivo via multiple methods. We confirmed that circFTO was up regulated in ccRCC and correlated with a more aggressive phenotype. The up regulated circFTO could sponge and block the function of miR-514b-3p, a reported tumor suppressor, and caused overexpression of DUSP4. DUSP4 was found to lead to KRAS/ERK pathway activation, increased epithelial-mesenchymal transition (EMT) and inhibition of autophagy in ccRCC cells, which in the end boosted the proliferation and invasiveness of ccRCC. We thus concluded that circFTO/miR-514b-3p/DUSP4 axis may play an important role in ccRCC development and could be a potential biomarker and therapeutic target.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article